The invention discloses a novel antibacterial and antiviral marine actinomycete. The actinomycete is prepared through the following steps: implanting streptomycetes, small single cell bacteria, Rhodococcus rhodococcus, Nocard's bacillus and Actinoplanes in maifanite used as a carrier, pouring the maifanite into a mixer at 20-37 DEG C, mixing the maifanite for 30 min, and culturing the carrier attached with the above thalluses for 3-5 d. The antibacterial and antiviral principle of the marine actinomycete is generation of extracellular enzyme in the culturing of the streptomycetes, small singlecell bacteria, Rhodococcus rhodococcus, Nocard's bacillus and Actinoplanes attached to the maifanite. The marine actinomycete is a highly-adaptable decomposing bacterium, can resist a high temperature, a high pressure, a high salt and low nutrition, has no toxic or side effects, has anti-bacterium, antivirus, anti-Leptospira, detoxification, antitumor and leukemia cell-destruction effects, and can effectively improve the immunity.